Protease‐activated receptor‐2 accelerates intestinal tumor formation through activation of nuclear factor‐κB signaling and tumor angiogenesis in ApcMin/+ mice
Open Access
- 30 January 2020
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 111 (4), 1193-1202
- https://doi.org/10.1111/cas.14335
Abstract
Hepatocyte growth factor activator inhibitor‐1 (HAI‐1), encoded by the SPINT1 gene, is a membrane‐bound protease inhibitor expressed on the surface of epithelial cells. Hepatocyte growth factor activator inhibitor‐1 regulates type II transmembrane serine proteases that activate protease‐activated receptor‐2 (PAR‐2). We previously reported that deletion of Spint1 in ApcMin/+ mice resulted in accelerated formation of intestinal tumors, possibly through enhanced nuclear factor‐κB signaling. In this study, we examined the role of PAR‐2 in accelerating tumor formation in the ApcMin/+ model in the presence or absence of Spint1. We observed that knockout of the F2rl1 gene, encoding PAR‐2, not only eliminated the enhanced formation of intestinal tumors caused by Spint1 deletion, but also reduced tumor formation in the presence of Spint1. Exacerbation of anemia and weight loss associated with HAI‐1 deficiency was also normalized by compound deficiency of PAR‐2. Mechanistically, signaling triggered by deregulated protease activities increased nuclear translocation of RelA/p65, vascular endothelial growth factor expression, and vascular density in ApcMin/+‐induced intestinal tumors. These results suggest that serine proteases promote intestinal carcinogenesis through activation of PAR‐2, and that HAI‐1 plays a critical tumor suppressor role as an inhibitor of matriptase, kallikreins, and other PAR‐2 activating proteases.Funding Information
- Japan Society for the Promotion of Science (15K08311, 16H05175, 17K08764)
- Agence Nationale de la Recherche (ANR‐15‐CE14‐0009)
This publication has 67 references indexed in Scilit:
- Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impactCell Communication and Signaling, 2013
- MicroRNA-34a Mediates the Autocrine Signaling of PAR2-Activating Proteinase and Its Role in Colonic Cancer Cell ProliferationPLOS ONE, 2013
- Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesisOncogene, 2011
- Kallikrein-Related Peptidase 14 Acts on Proteinase-Activated Receptor 2 to Induce Signaling Pathway in Colon Cancer CellsThe American Journal of Pathology, 2011
- Membrane-Bound Serine Protease Inhibitor HAI-1 Is Required for Maintenance of Intestinal Epithelial IntegrityThe American Journal of Pathology, 2011
- Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndromeNature Genetics, 2010
- Local Protease Signaling Contributes to Neural Tube Closure in the Mouse EmbryoDevelopmental Cell, 2010
- Role of Tissue Factor in CancerJournal of Clinical Oncology, 2009
- Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndromeThe Journal of Experimental Medicine, 2009
- Nuclear factor-κB in cancer development and progressionNature, 2006